Skip to content

Author

P. Garbayo-Salmons

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Window of Opportunity and Predictors of Sustained Remission in Patients with Hidradenitis Suppurativa Treated with Adalimumab: A 540-Patient Cohort Study

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease. Predicting responses of “prolonged disease-free remission” to biological therapy is essential for identifying a “window of opportunity” for disease modification. A retrospective multicenter cohort study (2015–2023) of 540 patients with HS treated wit...

E. Vilarrasa, P. Garbayo-Salmons, E. Masferrer et al. · 1 citation
Review Open access Oct 2026

Upcoming novel treatments for hidradenitis suppurativa: An overview of the pipeline.

The expanding therapeutic pipeline in HS reflects a shift towards precision medicine and pathway-specific interventions, and novel biologics, dual cytokine-inhibition strategies and bispecific agents represent an emerging therapeutic paradigm.

T. Tzellos, A. Liakou, P. Garbayo-Salmons et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.